Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects

Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects

Polycystic ovary syndrome (PCOS) is the most prevalent endocrine and metabolic disorder in premenopausal women, characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Patients frequently present comorbidities, including obesity, insulin resistance, and impaired glucose and...

Full description

Bibliographic Details
Main Authors: Lara Mastnak, Rok Herman, Simona Ferjan, Andrej Janež, Mojca Jensterle
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Life
Subjects:
polycystic ovary syndrome
prolactin
metabolic homeostasis
cardiometabolic markers
dopamine agonist
Online Access:https://www.mdpi.com/2075-1729/13/11/2124

Internet

https://www.mdpi.com/2075-1729/13/11/2124

Similar Items